All the news Showing 8 of 18 articles from: FibrosisGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources US study provides 'real world' evidence about which patients with hepatitis C should be prioritised for therapy Michael Carter / 19 October 2015 For patients with hepatitis C virus (HCV) mono-infection, baseline fibrosis stage is strongly predictive of the medium-term risk of serious liver disease and death, investigators from the United States report in the ... Liver function and survival improve after treatment with Viekirax + Exviera regimen Liz Highleyman / 27 June 2015 People with hepatitis C who were treated with AbbVie's Viekirax plus Exviera or '3D' regimen saw improvements in liver function biomarkers, had better quality of life and had increased survival compared to ... Many hepatitis C patients with cirrhosis or advanced fibrosis face liver failure and liver cancer Liz Highleyman / 07 January 2015 Nearly one-third of chronic hepatitis C patients with liver cirrhosis and 12% with advanced fibrosis progressed to decompensation within five years, and 23% and 11%, respectively, died, according to a study presented ... In ELECTRON trial, 100% of hard-to-treat patients cured with sofosbuvir/ledipasvir plus ribavirin or GS-9669 Liz Highleyman / 05 November 2013 Interferon-free regimens of sofosbuvir and ledipasvir plus either ribavirin or GS-9669 taken for 12 weeks produced sustained response in 100% of treatment-experienced people with genotype 1 chronic hepatitis C virus (HCV) with advanced ... People with HIV/HCV co-infection and advanced liver fibrosis can rapidly develop decompensated liver disease Michael Carter / 10 September 2013 People living with HIV who have hepatitis C virus (HCV) co-infection and advanced liver fibrosis can rapidly develop decompensated liver disease even though they do not have cirrhosis of the liver, ... Blood tests OK for fibrosis diagnosis in hep C MedPage Today / 05 June 2013 Patients With Advanced Fibrosis And Cardiovascular Issues At Greater Risk For Mortality Liver Disease News from Medical News Today / 15 April 2013 Insulin resistance is a big risk factor for the progression of liver fibrosis in HIV/HCV co-infected people Michael Carter / 13 July 2012 Insulin resistance is associated with the progression of liver fibrosis in people co-infected with HIV and hepatitis C, Canadian researchers report in the online edition of AIDS. Earlier research has shown that ... ← Prev12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive